Iovanace Biotherapeutics (IOVA) PT Raised to $16 at TD Cowen Following Raised Outlook

September 29, 2026 10:00 AM

TD Cowen analyst Nicholas Lorusso raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $16.00 (from $10.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found